OrthoPediatrics price target lowered to $17 from $20 at Truist

Truist lowered the firm’s price target on OrthoPediatrics (KIDS) to $17 from $20 and keeps a Hold rating on the shares. The firm notes that sales upside relative to consensus was balanced across product segments and outside-U.S. business was strong geographically, but its price target on the stock is cut to reflect the recent group multiple compression, the analyst tells investors in a research note.